glp 1 coverage 2026 Starting July 1, 2026, Medicare has a new program called Medicare GLP-1 Bridge to help you pay for certain GLP-1 weight loss medicines. Read more (link in comments) 👇 👇👇 medicare coverage of glp-1 Bridge

Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1

Metwaly A, Reitmeier S, Haller D (2022) Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders

Related: What is NAD

These tests involved progressively increasing the workload, starting at 60 watts with a 15-W increment every minute, continuing until participants reached their physical limits

Engages GLP-1 receptors in the hypothalamus and hindbrain to reduce hunger, increase satiety, and lower overall energy intake the primary driver of the weight reduction observed in the STEP trial program